Literature DB >> 27408362

Development of Acute Promyelocytic Leukemia in a Patient With Gouty Arthritis on Long Term Colchicine.

Nurhilal Buyukkurt1, Asli Korur2, Can Boga3.   

Abstract

Colchicine is a frequently used drug in rheumatological diseases. Acute promyelocytic leukemia developed in a patient who used colchicine for gouty arthritis since 10 years is presented and the possible relation between the long term use of colchicine and hematological malignancies is discussed.

Entities:  

Keywords:  Acute promyelocytic leukemia; Colchicine; Genotoxicity

Year:  2015        PMID： 27408362      PMCID： PMC4925494          DOI： 10.1007/s12288-015-0523-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  5 in total

Review 1.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

2.  Increased risk of cancer among gout patients: a nationwide population study.

Authors:  Chang-Fu Kuo; Shue-Fen Luo; Lai-Chu See; I-Jun Chou; Yao-Fan Fang; Kuang-Hui Yu
Journal:  Joint Bone Spine       Date:  2011-11-15       Impact factor: 4.929

3.  Miniaturized flow cytometric in vitro micronucleus assay represents an efficient tool for comprehensively characterizing genotoxicity dose-response relationships.

Authors:  Steven M Bryce; Svetlana L Avlasevich; Jeffrey C Bemis; Souk Phonethepswath; Stephen D Dertinger
Journal:  Mutat Res       Date:  2010-09-06       Impact factor: 2.433

4.  Long-term colchicine therapy in a patient with Behçet's disease and acute promyelocytic leukemia.

Authors:  Hakan Ozdogu; Can Boga; Zerrin Yilmaz; Feride Iffet Sahin; Nebil Bal
Journal:  Rheumatol Int       Date:  2006-12-20       Impact factor: 3.580

5.  Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009.

Authors:  Eswar Krishnan; Linjun Chen
Journal:  Arthritis Res Ther       Date:  2013-11-06       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.